Clinical Trial Update: A Clinical Study of SHR-9539 in Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of SHR-9539 in patients with multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SHR-9539

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING